In a piece by Jef Akst, the magazine said CIRM “giveth and it taketh away.”
The Scientist piece, which credited the California Stem Cell Report, did not add a great deal to our report, but Akst wrote,
"'Termination is a last option,'" CIRM's chief communications officer Don Gibbons wrote in an email to The Scientist. 'We first work with grantees who are not progressing to get them back on track.'"
No comments:
Post a Comment